APO Research
Talk to an analyst

APO RESEARCH · REPORT

Severe Asthma Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Severe Asthma Treatment Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchSevere Asthma Treatment Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Severe Asthma Treatment Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Severe Asthma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Severe Asthma Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Severe Asthma Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Severe Asthma Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Severe Asthma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Severe Asthma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Severe Asthma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Severe Asthma Treatment include Teva Pharmaceutical, Suzhou Connect Biopharmaceuticals, Sanofi, Novartis, Roche, GlaxoSmithKline, AstraZeneca, Regeneron Pharmaceutical and Pieris Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Severe Asthma Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Severe Asthma Treatment market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Severe Asthma Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Severe Asthma Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Severe Asthma Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Severe Asthma Treatment Market by Company

Teva Pharmaceutical

Suzhou Connect Biopharmaceuticals

Sanofi

Novartis

Roche

GlaxoSmithKline

AstraZeneca

Regeneron Pharmaceutical

Pieris Pharma

Morphosys

Biosion

Avalo Therapeutics

AB Pharma

4D Pharma plc

Severe Asthma Treatment Segment by Type

lntravenous

Oral

Subcutaneous

lnhaled

Severe Asthma Treatment Segment by Application

Teenagers

Children

Adults

Severe Asthma Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Severe Asthma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Severe Asthma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Severe Asthma Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Severe Asthma Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Severe Asthma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of lntravenous Table 2. Major Company of Oral Table 3. Major Company of Subcutaneous Table 4. Major Company of lnhaled Table 5. Global Severe Asthma Treatment Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Severe Asthma Treatment Sales by Type (2021-2026) & (k units) Table 7. Global Severe Asthma Treatment Sales Market Share in Volume by Type (2021-2026) Table 8. Global Severe Asthma Treatment Sales by Type (2021-2026) & (US$ Million) Table 9. Global Severe Asthma Treatment Sales Market Share in Value by Type (2021-2026) Table 10. Global Severe Asthma Treatment Price by Type (2021-2026) & (US$/unit) Table 11. Global Severe Asthma Treatment Sales by Type (2027-2032) & (k units) Table 12. Global Severe Asthma Treatment Sales Market Share in Volume by Type (2027-2032) Table 13. Global Severe Asthma Treatment Sales by Type (2027-2032) & (US$ Million) Table 14. Global Severe Asthma Treatment Sales Market Share in Value by Type (2027-2032) Table 15. Global Severe Asthma Treatment Price by Type (2027-2032) & (US$/unit) Table 16. North America Severe Asthma Treatment Sales by Type (2021-2026) & (k units) Table 17. North America Severe Asthma Treatment Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Severe Asthma Treatment Sales by Type (2021-2026) & (k units) Table 19. Europe Severe Asthma Treatment Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Severe Asthma Treatment Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Severe Asthma Treatment Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Severe Asthma Treatment Sales by Type (2021-2026) & (k units) Table 23. Latin America Severe Asthma Treatment Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Severe Asthma Treatment Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Severe Asthma Treatment Sales by Type (2021-2026) & (US$ Million) Table 26. Severe Asthma Treatment Industry Trends Table 27. Severe Asthma Treatment Industry Drivers Table 28. Severe Asthma Treatment Industry Opportunities and Challenges Table 29. Severe Asthma Treatment Industry Restraints Table 30. Global Severe Asthma Treatment Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Severe Asthma Treatment Revenue Market Share by Company (2021-2026) Table 32. Global Severe Asthma Treatment Sales by Company (2021-2026) & (k units) Table 33. Global Severe Asthma Treatment Sales Share by Company (2021-2026) Table 34. Global Severe Asthma Treatment Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Severe Asthma Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Severe Asthma Treatment Major Company Production Sites and Headquarters Table 37. Global Severe Asthma Treatment Company, Product Type & Application Table 38. Global Severe Asthma Treatment Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Severe Asthma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Severe Asthma Treatment Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Severe Asthma Treatment Sales by Region (2021-2026) & (k units) Table 43. Global Severe Asthma Treatment Sales Market Share in Volume by Region (2021-2026) Table 44. Global Severe Asthma Treatment Sales by Region (2021-2026) & (US$ Million) Table 45. Global Severe Asthma Treatment Sales Market Share in Value by Region (2021-2026) Table 46. Global Severe Asthma Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Severe Asthma Treatment Sales by Region (2027-2032) & (k units) Table 48. Global Severe Asthma Treatment Sales Market Share in Volume by Region (2027-2032) Table 49. Global Severe Asthma Treatment Sales by Region (2027-2032) & (US$ Million) Table 50. Global Severe Asthma Treatment Sales Market Share in Value by Region (2027-2032) Table 51. Global Severe Asthma Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Severe Asthma Treatment Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Severe Asthma Treatment Sales by Application (2021-2026) & (k units) Table 54. Global Severe Asthma Treatment Sales Market Share in Volume by Application (2021-2026) Table 55. Global Severe Asthma Treatment Sales by Application (2021-2026) & (US$ Million) Table 56. Global Severe Asthma Treatment Sales Market Share in Value by Application (2021-2026) Table 57. Global Severe Asthma Treatment Price by Application (2021-2026) & (US$/unit) Table 58. Global Severe Asthma Treatment Sales by Application (2027-2032) & (k units) Table 59. Global Severe Asthma Treatment Sales Market Share in Volume by Application (2027-2032) Table 60. Global Severe Asthma Treatment Sales by Application (2027-2032) & (US$ Million) Table 61. Global Severe Asthma Treatment Sales Market Share in Value by Application (2027-2032) Table 62. Global Severe Asthma Treatment Price by Application (2027-2032) & (US$/unit) Table 63. North America Severe Asthma Treatment Sales by Application (2021-2026) & (k units) Table 64. North America Severe Asthma Treatment Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Severe Asthma Treatment Sales by Application (2021-2026) & (k units) Table 66. Europe Severe Asthma Treatment Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Severe Asthma Treatment Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Severe Asthma Treatment Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Severe Asthma Treatment Sales by Application (2021-2026) & (k units) Table 70. Latin America Severe Asthma Treatment Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Severe Asthma Treatment Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Severe Asthma Treatment Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Company Information Table 74. Teva Pharmaceutical Business Overview Table 75. Teva Pharmaceutical Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Severe Asthma Treatment Product Portfolio Table 77. Teva Pharmaceutical Recent Development Table 78. Suzhou Connect Biopharmaceuticals Company Information Table 79. Suzhou Connect Biopharmaceuticals Business Overview Table 80. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolio Table 82. Suzhou Connect Biopharmaceuticals Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Sanofi Severe Asthma Treatment Product Portfolio Table 87. Sanofi Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Novartis Severe Asthma Treatment Product Portfolio Table 92. Novartis Recent Development Table 93. Roche Company Information Table 94. Roche Business Overview Table 95. Roche Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Roche Severe Asthma Treatment Product Portfolio Table 97. Roche Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Severe Asthma Treatment Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. AstraZeneca Company Information Table 104. AstraZeneca Business Overview Table 105. AstraZeneca Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. AstraZeneca Severe Asthma Treatment Product Portfolio Table 107. AstraZeneca Recent Development Table 108. Regeneron Pharmaceutical Company Information Table 109. Regeneron Pharmaceutical Business Overview Table 110. Regeneron Pharmaceutical Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolio Table 112. Regeneron Pharmaceutical Recent Development Table 113. Pieris Pharma Company Information Table 114. Pieris Pharma Business Overview Table 115. Pieris Pharma Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Pieris Pharma Severe Asthma Treatment Product Portfolio Table 117. Pieris Pharma Recent Development Table 118. Morphosys Company Information Table 119. Morphosys Business Overview Table 120. Morphosys Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Morphosys Severe Asthma Treatment Product Portfolio Table 122. Morphosys Recent Development Table 123. Biosion Company Information Table 124. Biosion Business Overview Table 125. Biosion Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Biosion Severe Asthma Treatment Product Portfolio Table 127. Biosion Recent Development Table 128. Avalo Therapeutics Company Information Table 129. Avalo Therapeutics Business Overview Table 130. Avalo Therapeutics Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Avalo Therapeutics Severe Asthma Treatment Product Portfolio Table 132. Avalo Therapeutics Recent Development Table 133. AB Pharma Company Information Table 134. AB Pharma Business Overview Table 135. AB Pharma Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. AB Pharma Severe Asthma Treatment Product Portfolio Table 137. AB Pharma Recent Development Table 138. 4D Pharma plc Company Information Table 139. 4D Pharma plc Business Overview Table 140. 4D Pharma plc Severe Asthma Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. 4D Pharma plc Severe Asthma Treatment Product Portfolio Table 142. 4D Pharma plc Recent Development Table 143. North America Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. North America Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 145. North America Severe Asthma Treatment Sales Market Share by Country (2021-2026) Table 146. North America Severe Asthma Treatment Sales Forecast by Country (2027-2032) & (k units) Table 147. North America Severe Asthma Treatment Sales Market Share Forecast by Country (2027-2032) Table 148. North America Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Severe Asthma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Severe Asthma Treatment Market Share by Country (2021-2026) Table 151. North America Severe Asthma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Severe Asthma Treatment Market Share Forecast by Country (2027-2032) Table 153. Europe Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Europe Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 155. Europe Severe Asthma Treatment Sales Market Share by Country (2021-2026) Table 156. Europe Severe Asthma Treatment Sales Forecast by Country (2027-2032) & (k units) Table 157. Europe Severe Asthma Treatment Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Severe Asthma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Severe Asthma Treatment Market Share by Country (2021-2026) Table 161. Europe Severe Asthma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Severe Asthma Treatment Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 165. Asia-Pacific Severe Asthma Treatment Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Severe Asthma Treatment Sales Forecast by Country (2027-2032) & (k units) Table 167. Asia-Pacific Severe Asthma Treatment Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Severe Asthma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Severe Asthma Treatment Market Share by Country (2021-2026) Table 171. Asia-Pacific Severe Asthma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Severe Asthma Treatment Market Share Forecast by Country (2027-2032) Table 173. Latin America Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 174. Latin America Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 175. Latin America Severe Asthma Treatment Sales Market Share by Country (2021-2026) Table 176. Latin America Severe Asthma Treatment Sales Forecast by Country (2027-2032) & (k units) Table 177. Latin America Severe Asthma Treatment Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Severe Asthma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Severe Asthma Treatment Market Share by Country (2021-2026) Table 181. Latin America Severe Asthma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Severe Asthma Treatment Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 185. Middle East and Africa Severe Asthma Treatment Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Severe Asthma Treatment Sales Forecast by Country (2027-2032) & (k units) Table 187. Middle East and Africa Severe Asthma Treatment Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Severe Asthma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Severe Asthma Treatment Market Share by Country (2021-2026) Table 191. Middle East and Africa Severe Asthma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Severe Asthma Treatment Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Severe Asthma Treatment Distributors List Table 196. Severe Asthma Treatment Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Severe Asthma Treatment Image Figure 2. Global Severe Asthma Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Severe Asthma Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Severe Asthma Treatment Sales (2021-2032) & (k units) Figure 5. lntravenous Image Figure 6. Global lntravenous Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Image Figure 8. Global Oral Sales YoY Growth (2021-2032) & (k units) Figure 9. Subcutaneous Image Figure 10. Global Subcutaneous Sales YoY Growth (2021-2032) & (k units) Figure 11. lnhaled Image Figure 12. Global lnhaled Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Severe Asthma Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Severe Asthma Treatment Market Share by Type 2025 VS 2032 Figure 15. North America Severe Asthma Treatment Sales Market Share in Volume by Type in 2025 Figure 16. North America Severe Asthma Treatment Sales Market Share in Value by Type in 2025 Figure 17. Europe Severe Asthma Treatment Sales Market Share in Volume by Type in 2025 Figure 18. Europe Severe Asthma Treatment Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Severe Asthma Treatment Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Severe Asthma Treatment Sales Market Share in Value by Type in 2025 Figure 21. Latin America Severe Asthma Treatment Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Severe Asthma Treatment Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Severe Asthma Treatment Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Severe Asthma Treatment Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Severe Asthma Treatment Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Teenagers Image Figure 28. Global Teenagers Sales YoY Growth (2021-2032) & (k units) Figure 29. Children Image Figure 30. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 31. Adults Image Figure 32. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Severe Asthma Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Severe Asthma Treatment Market Share by Application 2025 VS 2032 Figure 35. North America Severe Asthma Treatment Sales Market Share in Volume by Application in 2025 Figure 36. North America Severe Asthma Treatment Sales Market Share in Value by Application in 2025 Figure 37. Europe Severe Asthma Treatment Sales Market Share in Volume by Application in 2025 Figure 38. Europe Severe Asthma Treatment Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Severe Asthma Treatment Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Severe Asthma Treatment Sales Market Share in Value by Application in 2025 Figure 41. Latin America Severe Asthma Treatment Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Severe Asthma Treatment Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Severe Asthma Treatment Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Severe Asthma Treatment Sales Market Share in Value by Application in 2025 Figure 45. North America Severe Asthma Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Severe Asthma Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Severe Asthma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Severe Asthma Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Severe Asthma Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Severe Asthma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Severe Asthma Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Severe Asthma Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Severe Asthma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Severe Asthma Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Severe Asthma Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Severe Asthma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Severe Asthma Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Severe Asthma Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Severe Asthma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Severe Asthma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Severe Asthma Treatment Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Severe Asthma Treatment Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • lntravenous
  • Oral
  • Subcutaneous
  • lnhaled
Applications
  • Teenagers
  • Children
  • Adults
Companies covered
  • Teva Pharmaceutical
  • Suzhou Connect Biopharmaceuticals
  • Sanofi
  • Novartis
  • Roche
  • GlaxoSmithKline
  • AstraZeneca
  • Regeneron Pharmaceutical
  • Pieris Pharma
  • Morphosys
  • Biosion
  • Avalo Therapeutics
  • AB Pharma
  • 4D Pharma plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Severe Asthma Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Severe Asthma Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Severe Asthma Treatment Market by Type
  6. 1.3.1 lntravenous
  7. 1.3.2 Oral
  8. 1.3.3 Subcutaneous
  9. 1.3.4 lnhaled
  10. 1.4 Global Severe Asthma Treatment Market Size by Type
  11. 1.4.1 Global Severe Asthma Treatment Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Severe Asthma Treatment Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Severe Asthma Treatment Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Severe Asthma Treatment Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Severe Asthma Treatment Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Severe Asthma Treatment Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Severe Asthma Treatment Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Severe Asthma Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Severe Asthma Treatment Industry Trends
  2. 2.2 Severe Asthma Treatment Industry Drivers
  3. 2.3 Severe Asthma Treatment Industry Opportunities and Challenges
  4. 2.4 Severe Asthma Treatment Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Severe Asthma Treatment Revenue (2021-2026)
  2. 3.2 Global Top Players by Severe Asthma Treatment Sales (2021-2026)
  3. 3.3 Global Top Players by Severe Asthma Treatment Price (2021-2026)
  4. 3.4 Global Severe Asthma Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Severe Asthma Treatment Major Company Production Sites & Headquarters
  6. 3.6 Global Severe Asthma Treatment Company, Product Type & Application
  7. 3.7 Global Severe Asthma Treatment Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Severe Asthma Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Severe Asthma Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Severe Asthma Treatment Tier 1, Tier 2, and Tier 3
4 Severe Asthma Treatment Regional Status and Outlook
  1. 4.1 Global Severe Asthma Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Severe Asthma Treatment Historic Market Size by Region
  3. 4.2.1 Global Severe Asthma Treatment Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Severe Asthma Treatment Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Severe Asthma Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Severe Asthma Treatment Forecasted Market Size by Region
  7. 4.3.1 Global Severe Asthma Treatment Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Severe Asthma Treatment Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Severe Asthma Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Severe Asthma Treatment by Application
  1. 5.1 Severe Asthma Treatment Market by Application
  2. 5.1.1 Teenagers
  3. 5.1.2 Children
  4. 5.1.3 Adults
  5. 5.2 Global Severe Asthma Treatment Market Size by Application
  6. 5.2.1 Global Severe Asthma Treatment Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Severe Asthma Treatment Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Severe Asthma Treatment Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Severe Asthma Treatment Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Severe Asthma Treatment Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Severe Asthma Treatment Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Severe Asthma Treatment Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Severe Asthma Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Severe Asthma Treatment Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Suzhou Connect Biopharmaceuticals
  8. 6.2.1 Suzhou Connect Biopharmaceuticals Company Information
  9. 6.2.2 Suzhou Connect Biopharmaceuticals Business Overview
  10. 6.2.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolio
  12. 6.2.5 Suzhou Connect Biopharmaceuticals Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Severe Asthma Treatment Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Severe Asthma Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Severe Asthma Treatment Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Severe Asthma Treatment Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Severe Asthma Treatment Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Regeneron Pharmaceutical
  44. 6.8.1 Regeneron Pharmaceutical Company Information
  45. 6.8.2 Regeneron Pharmaceutical Business Overview
  46. 6.8.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolio
  48. 6.8.5 Regeneron Pharmaceutical Recent Developments
  49. 6.9 Pieris Pharma
  50. 6.9.1 Pieris Pharma Company Information
  51. 6.9.2 Pieris Pharma Business Overview
  52. 6.9.3 Pieris Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pieris Pharma Severe Asthma Treatment Product Portfolio
  54. 6.9.5 Pieris Pharma Recent Developments
  55. 6.10 Morphosys
  56. 6.10.1 Morphosys Company Information
  57. 6.10.2 Morphosys Business Overview
  58. 6.10.3 Morphosys Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Morphosys Severe Asthma Treatment Product Portfolio
  60. 6.10.5 Morphosys Recent Developments
  61. 6.11 Biosion
  62. 6.11.1 Biosion Company Information
  63. 6.11.2 Biosion Business Overview
  64. 6.11.3 Biosion Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biosion Severe Asthma Treatment Product Portfolio
  66. 6.11.5 Biosion Recent Developments
  67. 6.12 Avalo Therapeutics
  68. 6.12.1 Avalo Therapeutics Company Information
  69. 6.12.2 Avalo Therapeutics Business Overview
  70. 6.12.3 Avalo Therapeutics Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Avalo Therapeutics Severe Asthma Treatment Product Portfolio
  72. 6.12.5 Avalo Therapeutics Recent Developments
  73. 6.13 AB Pharma
  74. 6.13.1 AB Pharma Company Information
  75. 6.13.2 AB Pharma Business Overview
  76. 6.13.3 AB Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AB Pharma Severe Asthma Treatment Product Portfolio
  78. 6.13.5 AB Pharma Recent Developments
  79. 6.14 4D Pharma plc
  80. 6.14.1 4D Pharma plc Company Information
  81. 6.14.2 4D Pharma plc Business Overview
  82. 6.14.3 4D Pharma plc Severe Asthma Treatment Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 4D Pharma plc Severe Asthma Treatment Product Portfolio
  84. 6.14.5 4D Pharma plc Recent Developments
7 North America by Country
  1. 7.1 North America Severe Asthma Treatment Sales by Country
  2. 7.1.1 North America Severe Asthma Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Severe Asthma Treatment Sales by Country (2021-2026)
  4. 7.1.3 North America Severe Asthma Treatment Sales Forecast by Country (2027-2032)
  5. 7.2 North America Severe Asthma Treatment Market Size by Country
  6. 7.2.1 North America Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Severe Asthma Treatment Market Size by Country (2021-2026)
  8. 7.2.3 North America Severe Asthma Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Severe Asthma Treatment Sales by Country
  2. 8.1.1 Europe Severe Asthma Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Severe Asthma Treatment Sales by Country (2021-2026)
  4. 8.1.3 Europe Severe Asthma Treatment Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Severe Asthma Treatment Market Size by Country
  6. 8.2.1 Europe Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Severe Asthma Treatment Market Size by Country (2021-2026)
  8. 8.2.3 Europe Severe Asthma Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Severe Asthma Treatment Sales by Country
  2. 9.1.1 Asia-Pacific Severe Asthma Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Severe Asthma Treatment Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Severe Asthma Treatment Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Severe Asthma Treatment Market Size by Country
  6. 9.2.1 Asia-Pacific Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Severe Asthma Treatment Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Severe Asthma Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Severe Asthma Treatment Sales by Country
  2. 10.1.1 South America Severe Asthma Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Severe Asthma Treatment Sales by Country (2021-2026)
  4. 10.1.3 South America Severe Asthma Treatment Sales Forecast by Country (2027-2032)
  5. 10.2 South America Severe Asthma Treatment Market Size by Country
  6. 10.2.1 South America Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Severe Asthma Treatment Market Size by Country (2021-2026)
  8. 10.2.3 South America Severe Asthma Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Severe Asthma Treatment Sales by Country
  2. 11.1.1 Middle East and Africa Severe Asthma Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Severe Asthma Treatment Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Severe Asthma Treatment Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Severe Asthma Treatment Market Size by Country
  6. 11.2.1 Middle East and Africa Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Severe Asthma Treatment Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Severe Asthma Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Severe Asthma Treatment Value Chain Analysis
  2. 12.1.1 Severe Asthma Treatment Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Severe Asthma Treatment Production Mode & Process
  7. 12.2 Severe Asthma Treatment Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Severe Asthma Treatment Distributors
  10. 12.2.3 Severe Asthma Treatment Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst